SCHEMBL2199068

SCHEMBL2199068

CC(C)c1ccc(N)c(C(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
GAA P10253 3/20 0.54
HTT P42858 2/20 0.54
ALOX12 P18054 1/20 0.54
HIF1A Q16665 1/20 0.54
LMNA P02545 1/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SCN4A P35499 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
TRPA1 O75762 1/20 0.40
PTGS1 P23219 1/20 0.40
CACNA1C Q13936 1/20 0.40
FABP3 P05413 2/20 0.39
FABP4 P15090 2/20 0.39
FABP5 Q01469 1/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28948703 0.98 ALDH1A1 (0.52) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL9818597 0.94 ALDH1A1 (0.48) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL2170424 0.88 GAA (0.42) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL10620755 0.87 ALDH1A1 (0.43) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL22068493 0.85 GAA (0.39) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL2244195 0.81 ALDH1A1 (0.59) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL741007 0.80 ALDH1A1 (0.64) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL29549360 0.80 ALDH1A1 (0.64) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL22326133 0.80 ESR1 (0.41) ALDH1A1GAAHTTALOX12HIF1A
SCHEMBL30189495 0.80 HIF1A (0.38) ALDH1A1GAAHTTALOX12HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008154353-A1 THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES CHARLESSON, LLC (US) 2008-12-18 WO claimed
US-20080306134-A1 THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES CHARLESSON, LLC 2008-12-11 US claimed
EP-4610287-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-09-03 EP disclosed
EP-4610285-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-09-03 EP disclosed
CN-120092029-A Resin composition, cured product, prepreg, metal foil-clad laminate, resin composite sheet, and printed wiring board 三菱瓦斯化学株式会社 2025-06-03 CN disclosed
CN-119899377-A Polymaleimide compound, curable composition, cured product, prepreg, circuit board, laminate film, semiconductor sealing material, and semiconductor device DIC株式会社 2025-04-29 CN disclosed
CN-119823190-A Preparation method of diimine nickel catalyst containing rigid trityl group and application of diimine nickel catalyst in olefin polymerization 安徽大学 2025-04-15 CN disclosed
CN-119191992-A Industrial preparation method of ortho-position large-steric-hindrance aniline 浙江巨化技术中心有限公司 2024-12-27 CN disclosed
EP-4395521-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE COMPRISING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS COMPRISING THE LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2024-07-03 EP disclosed
WO-2024090409-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD 三菱瓦斯化学株式会社 2024-05-02 WO disclosed
WO-2024090408-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD 三菱瓦斯化学株式会社 2024-05-02 WO disclosed
US-4436936-A ACID CATALYSTS CIBA-GEIGY CORPORATION (US) 1984-03-13 US disclosed
US-4379934-A Process for two-dimensionally concentrating light, and novel perylene-3,4,9,10-tetracarboxylic acid diimides BASF AKTIENGESELLSCHAFT (DE) 1983-04-12 US disclosed
EP-0073277-A1 Process for producing orthoalkylated aromatic amines MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1983-03-09 EP disclosed
EP-0069065-A1 Process for the alkylation or aralkylation of aromatic amines CIBA-GEIGY AG (CH) 1983-01-05 EP disclosed
US-4351958-A Process for producing orthoalkylated aromatic amine MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1982-09-28 US disclosed
EP-0033079-A1 Perylene-3,4,9,10-tetracarboxylic-acid diimides and their use BASF Aktiengesellschaft (DE) 1981-08-05 EP disclosed
US-4281127-A USEFUL AS ANTIALLERGENS HOFFMANN-LA ROCHE INC. (US) 1981-07-28 US disclosed
US-4173645-A INSECTICIDES, MITICIDES BAYER AKTIENGESELLSCHAFT (DE) 1979-11-06 US disclosed
US-4004029-A BENZAMIDES THE UPJOHN COMPANY (US) 1977-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306134-A1 THALIDOMIDE ANALOGS FOR TREATING VASCULAR ABNORMALITIES VEGFA, FLT1, VCAM1 ALDH1A1 750/4885GAA 328/4885HTT 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.